Natural Compounds in Cancer Therapy and Prevention 2.0

Dear Colleagues,

Cancer prevention and therapy represent the greatest challenges of our time, with major efforts being made to prevent cancer onset and progression and to pharmacologically treat oncologic patients. Currently, naturally derived drugs are used in clinics, such as vincristine, actinomycin D, bleomycin, doxorubicin, irinotecan and many others. However, due to the lack of effective therapeutic strategies for many cancers and the side effects associated with chemotherapy, we must identify new therapeutic approaches. In this context, natural extracts represent a source of new chemicals that could aid the development of new anticancer drugs. Similarly, it is well known that natural extracts may enable cancer prevention, mainly by exerting antioxidant and anti-inflammatory activities. In this context, the identification and the biological characterization of new compounds and the evaluation of their protective and therapeutic effects on cancer progression is of great interest.

The potential topics include, but are not limited to: the anticancer activity of natural compounds; the effects of natural compounds on tumor growth and migration; the antimetastatic activity of natural compounds; natural products in cancer prevention; the isolation and identification of pharmacologically active compounds from natural extracts; drug discovery; and the immunomodulatory activity of natural compounds. In the first volume, 16 papers were published. We invite you to read them publications and contribute to volume 2.0.

Dr. Federica Finetti
Dr. Lorenza Trabalzini
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• cancer therapy

  cancer prevention
• natural compounds
• metastasis, immunomodulation
• adjuvant therapy
• preventive therapy
• drug discovery
• natural drugs

• Natural Compounds in Cancer Therapy and Prevention in International Journal of Molecular Sciences (16 articles)